Neurocrine Biosciences

NBIX

Market cap $15.2B

Upgrade to unlock

Buy

Hold

Sell

10 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

Avg. target

$179

18% upside

High target

10 analyst ratings

positive

0 neutral

0%

negative

Analyst & Firm	Rating	Price Target	Upside Downside	Date
Morgan Stanley Jeffrey Hung 71% 1-yr NBIX win rate				11 Nov ‘25 19 days ago
JP Morgan Anupam Rama 100% 1-yr NBIX win rate				3 Nov ‘25 27 days ago
Truist Securities Danielle Brill 100% 1-yr NBIX win rate				30 Oct ‘25 1 month ago
Canaccord Genuity Sumant Kulkarni 75% 1-yr NBIX win rate				29 Oct ‘25 1 month ago
Citigroup Yigal Nochomovitz 100% 1-yr NBIX win rate				29 Oct ‘25 1 month ago
Stifel Paul Matteis 100% 1-yr NBIX win rate				29 Oct ‘25 1 month ago
RBC Capital Brian Abrahams 100% 1-yr NBIX win rate				29 Oct ‘25 1 month ago
Piper Sandler David Amsellem 75% 1-yr NBIX win rate				29 Oct ‘25 1 month ago
Needham Ami Fadia 100% 1-yr NBIX win rate				29 Oct ‘25 1 month ago
UBS Ashwani Verma 83% 1-yr NBIX win rate				9 Oct ‘25 1 month ago